Directori de persones
Izaskun Urdanibia Ascanio

Izaskun Urdanibia Ascanio

Grau: Doctor/a


iurdanibia(ELIMINAR)@irblleida.cat

Grups

Publicacions

  • Pont, M; Marques, M; Sorolla, MA; Parisi, E; Urdanibia, I; Morales, S; Salud, A; Sorolla, A

    Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research

    Cancers 15 -. .

    [doi:10.3390/cancers15174364]

  • Barceló, C; Sisó, P; de la Rosa, I; Megino-Luque, C; Navaridas, R; Maiques, O; Urdanibia, I; Eritja, N; Soria, X; Potrony, M; Calbet-Llopart, N; Puig, S; Matías-Guiu, X; Martí, RM; Macià, A

    M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors.

    BRITISH JOURNAL OF CANCER 127 1142-1152. .

    [doi:10.1038/s41416-022-01886-4]

  • Megino-Luque, C; Sisó, P; Mota-Martorell, N; Navaridas, R; de la Rosa I; Urdanibia, I; Alberti-Valls, M; Santacana, M; Pinyol, M; Bonifaci, N; Macià, A; Llobet-Navas, D; Gatius, S; Matias-Guiu, X; Eritja, N

    ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

    MOLECULAR ONCOLOGY 16 2235-2259. .

    [doi:10.1002/1878-0261.13193]

  • Marqués, M; Sorolla, MA; Urdanibia, I; Parisi, E; Hidalgo, I; Morales, S; Salud, A; Sorolla, A

    Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers?

    Cancers 14 -. .

    [doi:10.3390/cancers14051101]

  • Barceló C; Sisó P; Maiques O; García-Mulero S; Sanz-Pamplona R; Navaridas R; Megino C; Felip I; Urdanibia I; Eritja N; Soria X; Piulats JM; Penin RM; Dolcet, X; Matias-Guiu, X; Marti, RM; Macia, A

    T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF V600E melanoma: TTCCs are therapy target in BRAF V600E melanoma.

    JOURNAL OF INVESTIGATIVE DERMATOLOGY 140 1253-1265. .

    [doi:10.1016/j.jid.2019.11.014]

  • Salazar E; Salazar AM; Taylor P; Urdanibia I; Pérez K; Rodríguez-Acosta A; Sánchez EE; Guerrero B

    Contribution of endothelial cell and macrophage activation in the alterations induced by the venom of Micrurus tener tener in C57BL/6 mice.

    MOLECULAR IMMUNOLOGY 116 45-55. .

    [doi:10.1016/j.molimm.2019.09.009]

  • Dosil, MA; Navaridas, R; Mirantes, C; Tarragona, J; Eritja, N; Felip, I; Urdanibia, I; Megino, C; Domingo, M; Santacana, M; Gatius, S; Piñol C; Barcelo, C; Maiques, O; Macia, A; Velasco, A; Vaquero, M; Matias-Guiu, X; Dolcet, X

    Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis

    JOURNAL OF PATHOLOGY 247 72-85. .

    [doi:10.1002/path.5168]

Projectes

  • Inteligencia Artificial basada en Patología y Transcriptómica Espacial para la identificación de la clase Inflamada del Adenocarcinoma Gástrico y la predicción de respuesta a Inmunoterapia.
  • Diseño y testaje de péptidos de interferencia para el tratamiento del cáncer de mama triple negativo
  • IRBLLEIDA-INTERNATIONAL POSTDOCTORAL PROGRAMM - COFUND